Work

Supplementary Figure Legend from A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file, 48K.

DOI: 10.1158/1078-0432.22451090.v1

Authors: Angeles Alvarez Secord, Deanna K. Teoh, William T. Barry, Miao Yu, Gloria Broadwater, Laura J. Havrilesky, Paula S. Lee, Andrew Berchuck, Johnathan Lancaster, Robert M. Wenham

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361908562

Cites:

Cited by:

Related to: 10